Translational Development Acquisition Overview
- Year Founded
-
2022
- Status
-
Public
- Employees
-
2
- Stock Symbol
-
TDAC
- Investments
-
1
- Share Price
-
$10.88
- (As of Thursday Closing)
Translational Development Acquisition General Information
Description
Translational Development Acquisition Corp is a newly organized blank check company.
Contact Information
Corporate Office
- 52 East 83 Road Street
- New York, NY 10028
- United States
Corporate Office
- 52 East 83 Road Street
- New York, NY 10028
- United States
Translational Development Acquisition Stock Performance
As of 12-Nov-2026, Translational Development Acquisition’s stock price is $10.88. Its current market cap is $210M with 19.3M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.88 | $10.88 | $10.41 - $10.95 | $210M | 19.3M | 10.6K | $0.26 |
Translational Development Acquisition Financials Summary
As of 30-Jun-2026, Translational Development Acquisition has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 206,886 | 229,863 | ||
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | 5,536 | 6,362 | (71) | (486) |
| Net Income | 5,536 | 6,362 | (71) | (486) |
| Total Assets | 157,367 | 181,697 | 175,001 | 2 |
| Total Debt | 1,100 | 200 | 0 | 348 |
Translational Development Acquisition Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Translational Development Acquisition Signals
Translational Development Acquisition Acquisitions (1)
Translational Development Acquisition’s most recent deal was a Reverse Merger with ProLogium. The deal was made on 27-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ProLogium | 27-May-2026 | Reverse Merger | Electrical Equipment |
Translational Development Acquisition ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Diversified Financials
Industry
Rank
Percentile
Asset Management and Custody Services
Subindustry
Rank
Percentile
Translational Development Acquisition FAQs
-
When was Translational Development Acquisition founded?
Translational Development Acquisition was founded in 2022.
-
Where is Translational Development Acquisition headquartered?
Translational Development Acquisition is headquartered in New York, NY.
-
What is the size of Translational Development Acquisition?
Translational Development Acquisition has 2 total employees.
-
What industry is Translational Development Acquisition in?
Translational Development Acquisition’s primary industry is Special Purpose Acquisition Company (SPAC).
-
Is Translational Development Acquisition a private or public company?
Translational Development Acquisition is a Public company.
-
What is Translational Development Acquisition’s stock symbol?
The ticker symbol for Translational Development Acquisition is TDAC.
-
What is the current stock price of Translational Development Acquisition?
As of 12-Nov-2026 the stock price of Translational Development Acquisition is $10.88.
-
What is the current market cap of Translational Development Acquisition?
The current market capitalization of Translational Development Acquisition is $210M.
-
What is Translational Development Acquisition’s annual earnings per share (EPS)?
Translational Development Acquisition’s EPS for 12 months was $0.26.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process